Role of Steroids in Tubercular Pleural Effusion

Role of Corticosteroids in Tubercular Pleural Effusion: A Randomized Controlled Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028513

Enrollment

Registered

2020-10-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A156- Tuberculous pleurisy

Interventions

Intervention1: Corticosteroid role in tubercular pleural effusion: Use of Prednisolone 1mg/kg/day for 15 days with anti tubercular drugs(ATT) in case. and only ATT in control group. and compare the re

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having moderate to massive pleural effusion. 2) Those who give inform consent for study.

Exclusion criteria

Exclusion criteria: 1) Patient shifted to institute ICU. 2) Consent not given by patient or legal attendant

Design outcomes

Primary

Measure	Time frame
Time of resolution of pleural effusion. Timepoint: 15 days and 30 days	—

Secondary

Measure	Time frame
Presence or absence of pleural thickeningTimepoint: 15 days and 30 days	—

Countries

India

Contacts

Public ContactAjit Kumar

IMS, BHU Varanasi (UP)

ajtkm1988@gmail.com8840929634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026